全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Diabetes Screening and Cardiovascular Risk in Tuberculosis Patients in Conakry and Surrounding Towns

DOI: 10.4236/ojemd.2024.141002, PP. 7-13

Keywords: Screening, Diabetes, Tuberculosis, Cardiovascular Risk, Conakry

Full-Text   Cite this paper   Add to My Lib

Abstract:

Objective: To determine the prevalence of diabetes and the level of cardiovascular risk in tuberculosis patients treated in Conakry and surrounding towns. Method: This was a cross-sectional study carried out at tuberculosis treatment centers in Conakry and surrounding towns (Coyah and Dubréka) on World TB Day, November 14, 2022, among 350 tuberculosis patients. We determined the proportion of TB patients with diabetes and high hyperglycemia. We determined the Chi-square to identify the factors associated with the occurrence of diabetes in tuberculosis patients, and a significance threshold with p < 0.05 was considered. Results: The average age of participants was 33.5 ± 14.5 years, and they were predominantly male (59.7%). The majority of participants lived in Conakry (96.3%). 5.7% were known diabetics and 4.6% were known hypertensives. We found a prevalence of diabetes of 9.4%. Among diabetics, 39% were diabetes discoveries. 30% were hypertensive or had high blood pressure. Of these hypertensive patients, 26.4% were unrecognized hypertensives. Age and hypertension were statistically significantly associated with the onset of diabetes in tuberculosis patients. Medium, high and very high levels of cardiovascular risk were present in 23.4%, 8.9% and 3.4% respectively. Conclusion: Diabetes is common in tuberculosis patients. Cardiovascular risk factors, notably hypertension and cardiovascular risk level, are frequently associated with tuberculosis. Tuberculosis patients with cardiovascular risk factors should be screened for diabetes.

References

[1]  Mjid, M., Cherif, J., Salah, N.B., Toujani, S., Ouahchi, Y., Zakhama, H., et al. (2015) épidémiologie de la tuberculose. Revue de Pneumologie Clinique, 71, 67-72.
https://doi.org/10.1016/j.pneumo.2014.04.002
[2]  Bagcchi, S. (2023) WHO’s Global Tuberculosis Report 2022. The Lancet Microbe, 4, E20.
https://doi.org/10.1016/S2666-5247(22)00359-7
[3]  Lee, M.R., Huang, Y.P., Kuo, Y.T., Luo, C.H., Shih, Y.J., Shu, C.C., et al. (2016) Diabetes Mellitus and Latent Tuberculosis Infection: A Systemic Review and Meta-Analysis. Clinical Infectious Diseases, 64, 719-727.
https://doi.org/10.1093/cid/ciw836
[4]  Jeon, C.Y. and Murray, M.B. (2008) Diabetes Mellitus Increases the Risk of Active Tuberculosis: A Systematic Review of 13 Observational Studies. PLOS Medicine, 5, e152.
https://doi.org/10.1371/journal.pmed.0050152
[5]  Antonio-Arques, V., Franch-Nadal, J. and Caylà, J.A. (2021) Diabetes y Tuberculosis: Una sindemia complicada por la COVID-19. Medicina Clínica, 157, 288-293.
https://doi.org/10.1016/j.medcli.2021.04.004
[6]  Asefzadeh, M., Bijani, B. and Kalantari, Z. (2008) Determine the Prevalence of Tuberculose Infection in Diabetic Patients in Qazvin. Journal of the Guilan University of Medical Sciences, 17, 38-47.
[7]  Djénèbou, T., Sylla, S.D., Djibril, S., et al. (2020) La Tuberculose chez le Sujet Diabétique à Bamako. Health Sciences and Disease, 21, 15-20.
[8]  Al-Rifai, R.H., Pearson, F., Critchley, J.A. and Abu-Raddad, L.J. (2007) Association between Diabetes Mellitus and Active Tuberculosis: A Systematic Review and Meta-Analysis. PLOS ONE, 12, e0187967.
https://doi.org/10.1371/journal.pone.0187967
[9]  Hayashi, S. and Chandramohan, D. (2018) Risk of Active Tuberculosis among People with Diabetes Mellitus: Systematic Review and Meta-Analysis. Tropical Medicine & International Health, 23, 1058-1070.
https://doi.org/10.1111/tmi.13133
[10]  Faurholt-Jepsen, D., Range, N., Praygod, G., Kidola, J., Faurholt-Jepsen, M., Aabye, M.G., et al. (2012) The Role of Diabetes Co-Morbidity for Tuberculosis Treatment Outcomes: A Prospective Cohort Study from Mwanza, Tanzania. BMC Infectious Diseases, 12, Article No. 165.
https://doi.org/10.1186/1471-2334-12-165
[11]  Kwas, H., Guermazi, E., Zendah, I., Khattab, A., Khouaja, I. and Ghédira, H. (2016) Effects of Diabetes on Pulmonary Tuberculosis. Revue des Maladies Respiratoire, 33, A140.
https://doi.org/10.1016/j.rmr.2015.10.259
[12]  Steen, T.W. and Mazonde, G.N. (1999) Ngaka ya setswana, ngaka ya sekgoa or Both? Health Seeking Behaviour in Batswana with Pulmonary Tuberculosis. Social Science & Medicine, 48, 163-172.
https://doi.org/10.1016/S0277-9536(98)00329-3
[13]  Boivin, J.M., Souris, M., Bauduceau, B., Sultan, A., Lamiral, Z. and Guerci, B. (2021) Perception of Vulnerability and Vaccination in Type 2 Diabetics. Médecine des Maladies Métaboliques, 15, 215-223.
https://doi.org/10.1016/j.mmm.2020.12.003
[14]  Sultan, A. and Halimi, S. (2021) Relationship between Type 2 Diabetes and COVID-19: The Latest Data. Médecine des Maladies Métaboliques, 15, 9-14.
https://doi.org/10.1016/j.mmm.2020.12.008
[15]  Baldé, N.M., Camara, A., Camara, L.M., Diallo, M.M., Kaké, A. and Bah Sow, O.Y. (2006) Tuberculosis and Diabetes in Conakry, Guinea: Prevalence and Clinical Features of the Association. The International Journal of Tuberculosis and Lung Disease, 10, 1036-1040.
[16]  Diarra, B., Diallo, A., Maiga, M., Sanogo, M., Diallo, M.H., Baya, B., et al. (2014) Tuberculosis and Diabetes in Bamako, Mali: Prevalence and Epidemioclinical Features of the Association. Revue Malienne d’Infectiologie et de Microbiologie Tome, 2, 29-40.
[17]  Sidibé, A.T., Dembelé, M., Diarra, A.S., Cissé, I., Bocoum, A., Traoré, A.K., et al. (2005) Pulmonary Tuberculosis in Diabetic Subjects in Internal Medicine at Point G Hospital, Bamako-Mali. Mali Medical, 20, 25.
[18]  World Health Organization (2016) Global Diabetes Report.
[19]  World Health Organization (2022) Global Tuberculosis Report 2022.
https://www.who.int/publications-detail-redirect/9789240061729
[20]  Bah, H., Cisse, F.A., Camara, L.M., Diallo, O.H., Diallo, M. and Sow, O.Y. (2012) Prevalence of Tuberculosis in Prisons in Conakry, Republic of Guinea. La Revue de Médecine Légale, 3, 146-150.
https://doi.org/10.1016/j.medleg.2012.06.003
[21]  Rorive, M., Letiexhe, M., Scheen, A. and Ziegler, O. (2005) Obesite et diabete de type 2. Revue Médicale de Liège, 60, Page.
[22]  Touze, J.E. (2007) Cardiovascular Disease and the Epidemiological Transition of the Tropical World. Médecine Tropicale, 67, 541-542.
[23]  Nibouche, W.N. and Biad, A. (2016) Arterial Hypertension at the Time of Diagnosis of Type 2 Diabetes in Adults. Annales de Cardiologie et d’Angéiologie, 65, 152-158.
https://doi.org/10.1016/j.ancard.2016.04.017
[24]  Monabeka, H.G., Bouenizabila, E., Mupangu, M., Kibangou, N. and Etitiele, F. (1998) Hypertension and Diabetes Mellitus about 152 Hypertensive Diabetics. Médecine d’Afrique Noire, 45, 106-109.
[25]  Togo, A., Kane, A., Traore, H., Diaby, L., Sanogo, A., Diawara, O., et al. (2018) Relationship between Periodontal Disease and Cardiovascular Disease: A Review of the Literature. Revue Malienne d’Infectiologie et de Microbiologie, 11, 60-65.
[26]  Rasoariseheno, F.J., Raveloson, F.H.R., Rakotoarivony, A.E., Andrianavony, N.R., Rabearivony, N., Ralison, G., et al. (2012) Relationship between Periodontal Disease and Cardiovascular Disease in Madagascar. Rev D’odontostomatologie Malgache En Ligne, 5, 16-26.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133